Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus

2009/12/28 by Nicholas Simpson, Paul A. Gatenby, Anastasia Wilson +12 · 27 citations
Immunology and Microbiology · Medicine · Biochemistry, Genetics and Molecular Biology · #T-cell and B-cell Immunology #Systemic Lupus Erythematosus Research #Diabetes and associated disorders

paper · doi:10.1002/art.25032

Abstract

OBJECTIVE: In the sanroque mouse model of lupus, pathologic germinal centers (GCs) arise due to increased numbers of follicular helper T (Tfh) cells, resulting in high-affinity anti-double-stranded DNA antibodies that cause end-organ inflammation, such as glomerulonephritis. The purpose of this study was to examine the hypothesis that this pathway could account for a subset of patients with systemic lupus erythematosus (SLE). METHODS: An expansion of Tfh cells is a causal, and therefore consistent, component of the sanroque mouse phenotype. We validated the enumeration of circulating T cells resembling Tfh cells as a biomarker of this expansion in sanroque mice, and we performed a comprehensive comparison of the surface phenotype of circulating and tonsillar Tfh cells in humans. This circulating biomarker was enumerated in SLE patients (n = 46), Sjögren's syndrome patients (n = 17), and healthy controls (n = 48) and was correlated with disease activity and end-organ involvement. RESULTS: In sanroque mice, circulating Tfh cells increased in proportion to their GC counterparts, making circulating Tfh cells a feasible human biomarker of this novel mechanism of breakdown in GC tolerance. In a subset of SLE patients (14 of 46), but in none of the controls, the levels of circulating Tfh cells (defined as circulating CXCR5+CD4+ cells with high expression of Tfh-associated molecules, such as inducible T cell costimulator or programmed death 1) were increased. This cellular phenotype did not vary with time, disease activity, or treatment, but it did correlate with the diversity and titers of autoantibodies and with the severity of end-organ involvement. CONCLUSION: These findings in SLE patients are consistent with the autoimmune mechanism in sanroque mice and identify Tfh effector molecules as possible therapeutic targets in a recognizable subset of patients with SLE.

Citations

• Derivation of the sledai. A disease activity index for lupus patients
• Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus

Cited by

• The origins, function, and regulation of T follicular helper cells
• Could tolerance to DNA be broken in the gut in systemic lupus erythematosus?
• T cells as therapeutic targets in SLE. [europepmc]
• Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. [europepmc]
• Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. [europepmc]
• Follicular helper T cells in immunity and systemic autoimmunity. [europepmc]
• Taming lupus-a new understanding of pathogenesis is leading to clinical advances. [europepmc]
• The origins, function, and regulation of T follicular helper cells. [europepmc]
• Expansion of HIV-specific T follicular helper cells in chronic HIV infection. [europepmc]
• The pathogenesis of systemic lupus erythematosus-an update. [europepmc]
• The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. [europepmc]
• Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. [europepmc]
• Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. [europepmc]
• Phenotype and functions of memory Tfh cells in human blood. [europepmc]
• T follicular helper cell differentiation, function, and roles in disease. [europepmc]
• Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. [europepmc]
• Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. [europepmc]
• Pathophysiology of T follicular helper cells in humans and mice. [europepmc]
• T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. [europepmc]
• OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response. [europepmc]
• T follicular regulatory cells in the regulation of B cell responses. [europepmc]
• Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies. [europepmc]
• ICOS Co-Stimulation: Friend or Foe? [europepmc]
• Immunoporosis: Immunology of Osteoporosis-Role of T Cells. [europepmc]
• scFTD-seq: freeze-thaw lysis based, portable approach toward highly distributed single-cell 3' mRNA profiling. [europepmc]
• PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. [europepmc]
• CD4 T Helper Cell Subsets and Related Human Immunological Disorders. [europepmc]

Related

• Cellular and molecular determinants mediating the dysregulated germinal center immune dynamics in systemic lupus erythematosus
• Extrafollicular responses in humans and SLE
• Follicular helper- and peripheral helper-like T cells drive autoimmune disease in human immune system mice
• Defective B cell tolerance in SLE lymph nodes underpins VH 4-34 “clonal damnation” and PD-1⁺TOX⁺ autoreactive B cells expansion
• Expansion of extrafollicular B and T cell subsets in childhood-onset systemic lupus erythematosus